A critical review and meta-analysis of the association between overt hyperthyroidism and mortality

European Journal of Endocrinology

Volumn 165, Issue 4, 2011, Pages 491-497

  Brandt, Frans ^a   Green, Anders ^a,b   Hegedüs, Laszlo ^a   Brix, Thomas H ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CASE CONTROL STUDY; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTHYROIDISM; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; PEER REVIEW; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; THYROTOXICOSIS;

CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; HYPERTHYROIDISM; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 80053471370     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0299     Document Type: Review

References (41)

1. Wang C & Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinology and Metabolism Clinics of North America 1997 26 189-218. (doi:10.1016/S0889-8529(05)70240-1)
2. Bulow PI, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L & Rasmussen LB. Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. Journal of Clinical Endocrinology and Metabolism 2006 91 3830-3834. (doi:10.1210/jc.2006-0652)
3. Klein I & Danzi S. Thyroid disease and the heart. Circulation 2007 116 1725-1735. (doi:10.1161/CIRCULATIONAHA.106.678326)
4. Sheu JJ, Kang JH & Lin HC. Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study. Stroke 2010 41 961-966. (doi:10.1161/STROKEAHA.109.577742)
5. Lin HC, Yang LY & Kang JH. Increased risk of pulmonary embolism among patients with hyperthyroidism: a five-year follow-up study. Journal of Thrombosis and Haemostasis 2010 8 2176-2181. (doi:10.1111/j.1538-7836.2010. 03993.x)
6. Erem C, Ucuncu O, Yilmaz M, Kocak M, Nuhoglu I & Ersoz HO. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. Endocrine 2009 36 473-478. (doi:10.1007/s12020-009-9271-2)
7. Volzke H, Schwahn C, Wallaschofski H & Dorr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? Journal of Clinical Endocrinology and Metabolism 2007 92 2421-2429. (doi:10.1210/jc.2007-0179)
8. Juni P, Witschi A, Bloch R & Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. Journal of the American Medical Association 1999 282 1054-1060. (doi:10.1001/jama.282.11.1054)
9. DerSimonian R & Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986 7 177-188. (doi:10.1016/0197-2456(86)90046-2)
10. Higgins J, Thompson S, Deeks J & Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. Journal of Health Services Research and Policy 2002 7 51-61. (doi:10.1258/1355819021927674)
11. Davey SG, Egger M & Phillips AN. Meta-analysis. Beyond the grand mean? BMJ 1997 315 1610-1614. (Pubitemid 27522409)
12. Singer RB. Long-term comparativ mortality in hyperthyroid patients treated with radio-iodine, a cohort study in England. Journal of Insurance Medicine 2001 33 133-137.
13. Singer RB. Mortality in a complete 4-year follow up of 85-year-old residents of Leiden. Classified by serum level of thyrotropin and thyroxine. Journal of Insurance Medicine 2006 38 14-19.
14. Goldman MB, Monson RR & Maloof F. Cancer mortality in women with thyroid disease. Cancer Research 1999 50 2283-2289.
15. Hall P, Lundell G & Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinologica 1993 128 230-234. (Pubitemid 23100879)
16. Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J & Wiklund K. Cancer mortality after iodine-131 therapy for hyperthyroidism. International Journal of Cancer 1992 50 886-890. (doi:10.1002/ijc.2910500611)
17. Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS III, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL & Boice JD Jr. Cancer mortality following treatment for adult hyperthyroidism. Cooperative thyrotoxicosis therapy follow-up study group. Journal of the American Medical Association 1998 280 347-355. (doi:10.1001/jama.280.4.347)
18. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J & Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. New England Journal of Medicine 1998 338 712-718. (doi:10.1056/NEJM199803123381103)
19. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J & Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999 353 2111-2115. (doi:10.1016/S0140- 6736(98)12295-X)
20. Franklyn JA, Sheppard MC & Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. Journal of the American Medical Association 2005 294 71-80. (doi:10.1001/jama.294.1.71)
21. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865. (doi:10.1016/S0140-6736(01)06067-6)
22. Osman F, Gammage MD & Franklyn JA. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 2002 12 483-487. (doi:10.1089/ 105072502760143854)
23. Gussekloo J, van EE, de Craen AJ, Meinders AE, Frolich M &Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599. (doi:10.1001/jama.292.21.2591)
24. Nyrienda MJ, Clark DN, Finlaysa AR, Read J, Elders A, Brain M, Fox KA & Toft AD. Thyroid disease and increased cardiovascular risk. Thyroid 2005 15 718-724. (doi:10.1089/thy.2005.15.718)
25. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041. (doi:10.1001/jama.295.9.1033)
26. Flynn RW, Macdonald TM, Jung RT, Morris AD & Leese GP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism 2006 91 2159-2164. (doi:10.1210/jc.2005- 1833)
27. Osman F, Franklyn JA, Holder RL, Sheppard MC & Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. Journal of the American College of Cardiology 2007 49 71-81. (doi:10.1016/j.jacc.2006.08.042)
28. Bauer DC, Rodondi N, Stone KL & Hillier TA. Thyroid hormone use, hyperthyroidism and mortality in older women. American Journal of Medicine 2007 120 343-349. (doi:10.1016/j.amjmed.2006.04.034)
29. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H & Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 2190-2196. (doi:10.1210/jc.2006-2321)
30. Hoffman DA, McConahey WM, Diamond EL & Kurland LT. Mortality in women treated for hyperthyroidism. American Journal of Epidemiology 1982 115 243-254. (Pubitemid 12182303)
31. Hill AB. The environmental and disease: association or causation? Proceedings of the Royal Society of Medicine 1965 58 295-300.
32. Dorr M, Wolff B, Robinson DM, John U, Ludemann J, Meng W, Felix SB & Volzke H. The association of thyroid function with cardiac mass and left ventricular hypertrophy. Journal of Clinical Endocrinology and Metabolism 2005 90 673-677. (doi:10.1210/jc.2004-1554)
33. Roth RN & McAuliffe MJ. Hyperthyroidism and thyroid storm. Emergency Medicine Clinics of North America 1989 7 873-883. (Pubitemid 19271744)
34. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J &Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 2008 148 832-845. (Pubitemid 351786932)
35. Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E &Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. Journal of Clinical Endocrinology and Metabolism 1998 83 765-769. (doi:10.1210/jc.83.3.765)
36. Brix TH, Kyvik KO, Christensen K & Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. Journal of Clinical Endocrinology and Metabolism 2001 86 930-934. (doi:10.1210/jc.86.2.930)
37. Acton RT, Go RC & Roseman JM. Genetics and cardiovascular disease. Ethnicity and Disease 2004 14 2-16.
38. Herskind AM, McGue M, Holm NV, Sorensen TI, Harvald B &Vaupel JW. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Human Genetics 2006 97 319-323. (doi:10.1007/BF02185763)
39. Madden PA, Pedersen NL, Kaprio J, Koskenvuo MJ & Martin NG. The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Research 2004 7 82-97. (doi:10.1375/13690520460741471)
40. Martin N, Boomsma D & Machin G. A twin-pronged attack on complex traits. Nature Genetics 1997 17 387-392. (doi:10.1038/ng1297-387)
41. Higgins JP, Thompson SG, Deeks JJ & Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 557-560. (doi:10.1136/bmj.327.7414. 557)